The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors Pharmaceutical Investing
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression Life Science Investing
Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025 Pharmaceutical Investing
Pfizer Invites Public to View and Listen to Webcast of April 29 Conference Call with Analysts Pharmaceutical Investing
